PROQR THERAPEUTICS N.V. Ordinary Shares (nominal value €0.04 per share) Controlled Equity OfferingSM Sales AgreementProQR Therapeutics N.V. • October 2nd, 2015 • Pharmaceutical preparations • New York
ProQR Therapeutics N.V., a Dutch public company with limited liability (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
